Literature DB >> 23578356

Family history of coronary heart disease and markers of subclinical cardiovascular disease: where do we stand?

Arvind K Pandey1, Shivda Pandey, Michael J Blaha, Arthur Agatston, Theodore Feldman, Michael Ozner, Raul D Santos, Matthew J Budoff, Roger S Blumenthal, Khurram Nasir.   

Abstract

OBJECTIVE: The goals of this systematic analysis are to determine the association between family history of coronary heart disease (CHD) and markers of subclinical cardiovascular disease as well as to discuss the inclusion of CHD family history in the frequently used coronary risk prediction algorithms.
BACKGROUND: Individuals with a family history of CHD are at high risk for developing atherosclerosis and events related to CHD, regardless of the presence of other coronary risk factors. They form a target population that might benefit from primary prevention strategies; however, family history data is not a part of the frequently used risk prediction algorithms.
METHODS: Medline and PubMed databases were searched for all studies evaluating the relationship between measures of subclinical atherosclerosis and family history of CHD, published till June 2010.
RESULTS: Thirty-two studies met the above criteria and were included in this review. Coronary artery calcium, carotid intima thickness, vascular function, and inflammatory markers including C reactive protein, fibrinogen, and D-dimer were used as measures of subclinical atherosclerosis. Studies differed in design, demographic data of the population, techniques and validation of family history information. Most studies established a statistically significant relationship between the above markers and family history of CAD; further, the association was noted to be independent of traditional risk factors.
CONCLUSION: Family history of CAD is associated with markers of subclinical atherosclerosis, and this relationship remains statistically significant after adjusting for traditional risk factors. The above data suggest these individuals should be considered strongly as candidates for assessment of subclinical CVD to further refine risk and treatment goals.
Copyright © 2013. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23578356     DOI: 10.1016/j.atherosclerosis.2013.02.016

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  15 in total

1.  A Simple Modified Framingham Scoring System to Predict Obstructive Coronary Artery Disease.

Authors:  Yong Liu; Qiang Li; Shiqun Chen; Xia Wang; Yingling Zhou; Ning Tan; Jiyan Chen
Journal:  J Cardiovasc Transl Res       Date:  2018-10-12       Impact factor: 4.132

2.  Family history of myocardial infarction, stroke and diabetes and cardiometabolic markers in children.

Authors:  Nina E Berentzen; Alet H Wijga; Lenie van Rossem; Gerard H Koppelman; Bo van Nieuwenhuizen; Ulrike Gehring; Annemieke M W Spijkerman; Henriëtte A Smit
Journal:  Diabetologia       Date:  2016-05-30       Impact factor: 10.122

Review 3.  Genetic Risk, Adherence to a Healthy Lifestyle, and Ischemic Heart Disease.

Authors:  Thomas F Whayne; Sibu P Saha
Journal:  Curr Cardiol Rep       Date:  2019-01-10       Impact factor: 2.931

4.  Machine learning models for prediction of co-occurrence of diabetes and cardiovascular diseases: a retrospective cohort study.

Authors:  Ahmad Shaker Abdalrada; Jemal Abawajy; Tahsien Al-Quraishi; Sheikh Mohammed Shariful Islam
Journal:  J Diabetes Metab Disord       Date:  2022-01-12

5.  Does family history of metabolic syndrome affect the metabolic profile phenotype in young healthy individuals?

Authors:  Anna Lipińska; Magdalena Koczaj-Bremer; Krzysztof Jankowski; Agnieszka Kaźmierczak; Michał Ciurzyński; Aisha Ou-Pokrzewińska; Ewelina Mikocka; Zbigniew Lewandowski; Urszula Demkow; Piotr Pruszczyk
Journal:  Diabetol Metab Syndr       Date:  2014-06-26       Impact factor: 3.320

6.  Overweight and obesity in children with congenital heart disease: combination of risks for the future?

Authors:  Sandra Mari Barbiero; Caroline D'Azevedo Sica; Daniela Schneid Schuh; Claudia Ciceri Cesa; Rosemary de Oliveira Petkowicz; Lucia Campos Pellanda
Journal:  BMC Pediatr       Date:  2014-10-16       Impact factor: 2.125

7.  Stroke patients' knowledge about cardiovascular family history - the Norwegian Stroke in the Young Study (NOR-SYS).

Authors:  Halvor Øygarden; Annette Fromm; Kristin Modalsli Sand; Geir Egil Eide; Lars Thomassen; Halvor Naess; Ulrike Waje-Andreassen
Journal:  BMC Neurol       Date:  2015-03-12       Impact factor: 2.474

8.  Is Chronic Low Back Pain Associated with the Prevalence of Coronary Heart Disease when Genetic Susceptibility Is Considered? A Co-Twin Control Study of Spanish Twins.

Authors:  Matt Fernandez; Juan R Ordoñana; Jan Hartvigsen; Manuela L Ferreira; Kathryn M Refshauge; Juan F Sánchez-Romera; Marina B Pinheiro; Stephen J Simpson; John L Hopper; Paulo H Ferreira
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

Review 9.  Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis.

Authors:  Simone Filardo; Marisa Di Pietro; Alessio Farcomeni; Giovanna Schiavoni; Rosa Sessa
Journal:  Mediators Inflamm       Date:  2015-08-09       Impact factor: 4.711

10.  Detection of subclinical atherosclerosis and diastolic dysfunction in patients with schizophrenia.

Authors:  Cüneyt Unsal; Mustafa Oran; Hande Oktay Tureli; Seref Alpsoy; Sema Yeşilyurt; Mehtap Arslan; Birol Topcu; Osman Karakaya; Erhan Kurt
Journal:  Neuropsychiatr Dis Treat       Date:  2013-10-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.